Larvol Delta - Adcentrx-Therapeutics-Announces-First-Patient-Dosed-in-the-Phase-1ab-Study-of-ADRX0405-a-Potential-FirstinClass-ADC-Targeting-STEAP1-for-the-Treatment-of-Advanced-Solid-Tumors

ADRX-0405 - Adcentrx Therap

https://www.prnewswire.com/news-releases/adcentrx-therapeutics-announces-first-patient-dosed-in-the-phase-1ab-study-of-adrx-0405-a-potential-first-in-class-adc-targeting-steap1-for-the-treatment-of-advanced-solid-tumors-302342200.html

Jan 6, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next